08-07-01 - Baxter acquires ASTA Medica Oncology Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases BAXTER TO ADVANCE ITS POSITION IN ONCOLOGY WITH ACQUISITION OF ASTA MEDICA ONCOLOGY...
08-07-01 - UEbernahme Von Asta Medica Oncology Staerkt Position Von Baxter Im Onkologie-Bereich Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases UEBERNAHME VON ASTA MEDICA ONCOLOGY STAERKT POSITION VON BAXTER IM ONKOLOGIE-BEREICH Die...
08-07-01 - Baxter Renforce Sa Position En Oncologie Par L'Acquisition De Asta Medica Oncology Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases BAXTER RENFORCE SA POSITION EN ONCOLOGIE PAR L'ACQUISITION DE ASTA MEDICA ONCOLOGY L...
10-18-01 - Third quarter earnings Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases BAXTER DELIVERS STRONG THIRD QUARTER PERFORMANCE, WITH SALES INCREASING 13 PERCENT, EARNINGS...
11-01-01 - Baxter Schliesst UEbernahme Von ASTA Medica Oncology AB Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases BAXTER SCHLIESST UEBERNAHME VON ASTA MEDICA ONCOLOGY AB Die UEbernahme von ASTA Medica...
11-01-01 - Acquition of ASTA Medica Oncology Complete Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases BAXTER COMPLETES ITS ACQUISITION OF ASTA MEDICA ONCOLOGY Acquisition of ASTA Medica Oncology...
07-16-02 - Baxter Launches Mesnex (mesna) Tablets Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back to News Releases 2005 Archives 2004 Archives 2003 Archives 2002 Archives 2001 Archives News Release Home > About Baxter > News Room > News Releases BAXTER LAUNCHES MESNEX (mesna) TABLETS Oral Form of Uroprotectant Offers a...
Baxter U.S. - MESNEX (mesna) Tablets Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back To Oncology Chemoprotectants Cellular Therapies Speciality Collections MESNEX (mesna) Tablets Home > Products > Oncology > Chemoprotectant MESNEX tablets offer the option to substitute the iv administration of mesna ...
Baxter U.S. - Oncology Products Conditions Therapies Products Services About Baxter Baxter Worldwide > United States Training and Education Sustainability Contact Us - << Back To Products U.S.
Baxter U.S. - 2002 Archived News Releases States - October 3, 2002 : Baxter Expects Low-Double-Digit Sales, Mid-Teens EPS Growth for Full-Year 2002 - September 26, 2002 : Baxter Files Marketing Authorization Application to EMEA for First Plasma/Albumin Free Method Recombinant Factor VIII Hemophilia Therapy - September 24, 2002 : Baxter Pledges to Help Hospitals Reduce Waste Through Landmark Environmental Initiative -...
Baxter s Products & Services Directory page 14
author: Center for One Baxter
subject: For questions about our Products and Services
duplicates:http://www.baxter.com/customers/products_svcs/2003_products_and_services_directory.pdf
Baxter s Products & Services Directory page 12
author: Center for One Baxter
subject: For questions about our Products and Services
duplicates:http://www.baxter.com/customers/products_svcs/2003_products_and_services_directory.pdf
Baxter s Products & Services Directory * Not for sale in the United States MERIDIAN HEMODIALYSIS INSTRUMENT 18 MESNEX 27 (MESNA) TABLETS 6, 16 MESNEX 27 (MESNA) INJECTION 16 METOCLOPRAMIDE INJECTION, USP 6 METRONIDAZOLE INJECTION 10 MICRO- INFUSION MANIFOLDS 9 MICROMIX PRODUCTS COMPOUNDER 7 COMPOUNDER TRANSFER SET 7 WEIGHING CHAMBER 7 MICRONUTRIENTS IN GLASS CONTAINERS 16.4% SODIUM ACETATE...
author: Center for One Baxter
subject: For questions about our Products and Services
Drug Approvals - M Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted M-Zole 3 Combination Pack [Miconazole Nitrate Vaginal Suppositories USP, 200 mg and Miconazole Cream USP, 2% (Combination package)], OTC, Alpharma ANDA 74-926 4/16/99 4/28/99 - 1/14/02 Macrobid (nitrofurantoin monohydrate/macrocrystals) Capsules,- Procter & Gamble NDA 20-064/S-014 10/31/03 11/5...
What is New Full prescribing information, including clinical trial information, safety, dosing, drug-drug interactions and contraindications is available at http://www.fda.gov/cder/foi/label/2002/21344lbl.pdf- On March 21, 2002 , the Food and Drug Administration (FDA) approved mesna tablets ( Mesnex , a trademark of Baxter Healthcare S.A.) as a prophylactic agent to reduce the...
author: Steve Hirschfeld
http://www.fda.gov/cder/orange/appendix_a.txt PEDIATRIC, ASCORBIC ACID M.V.I.-12 LYOPHILIZED, ASCORBIC ACID M.V.I.-12, ASCORBIC ACID MACROBID, NITROFURANTOIN MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE MACROTEC, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT MAGNACORT, HYDROCORTAMATE HYDROCHLORIDE MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE...
Mesnex 51-021853-00 letter 2px (mesna) Injection (mesna) Tablets DESCRIPTION Mesnex ® (mesna) is a detoxifying agent to inhibit the hemorrhagic cystitis induced by ifosfamide (IFEX ® )Mesnex Injection 240 mg/ m 2 THTH THTH Mesnex Tablets THTH 480 mg/ m 2 480...
author: Alysa Radtke
Mesnex 51-021853-00 letter 2px page 2
author: Alysa Radtke
duplicates:http://www.baxter.com/doctors/oncology/pdf/mesnex_pi.pdf
Mesnex 51-021853-00 letter 2px page 1
author: Alysa Radtke
duplicates:http://www.baxter.com/doctors/oncology/pdf/mesnex_pi.pdf
Mesnex 20855 Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search -Mesnex (mesna) Tablets Company:- Bristol-Myers Squibb Application No.:- 020855 Approval Date:-3/21/2002 Approval Letter(s) - Printed Labeling - Medical Review(s) - Part 1 - Part 2 - Chemistry Review(s) - Pharmacology Review(s) - Statistical Review(s) - Administrative...
author: USERNAME
Prescription and OTC Drug Product List 6/2002 -D- + WYETH AYERST 20,000 UNITS/VIAL N17055 003 JUN DISC -A- @ 20,000 UNITS/VIAL N17055 003 JUN DISC CHORIONIC GONADOTROPIN -D- + STERIS 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC -A- @ 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC GRANISETRON HYDROCHLORID E SOLUTION; ORAL KYTRIL -D- + ROCHE EQ 2MG BASE/10ML N21238 001 JUN 27, 2001 JUN DISC -A- @ EQ 2MG BASE/10ML N21238...
Prescription and OTC Drug Product List 3/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ALBUTEROL SULFATE AEROSOL, METERED; INHALATION PROVENTIL-HFA -D- + 3M EQ 0.09MG BASE/INH N20503 001 AUG 15, 1996 MAR CTEC -A- BX + EQ 0.09MG BASE/INH N20503 001 AUG 15, 1996 MAR CTEC VENTOLIN HFA -D- + GLAXOSMITHKLINE EQ 0.09MG BASE/INH N20983 001 APR 19, 2001 MAR CTEC -A- BX + EQ 0.09MG BASE/INH N20983 001 APR 19, 2001 MAR CTEC...
Document Information Page page 1
author: CDER USER
C:\Data\My Documents\NDAs\19884 s008 ap ltr.doc DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 NDA 19- 884/ S007, S008 NDA 20- 855 Baxter Healthcare Corporation Route 120 and Wilson Road; RLT- 10 Round Lake, IL 60073- 0490 Attention: Marcia Marconi V
author: Dotti Pease
C:\Data\My Documents\NDAs\19884 s008 ap ltr.doc page 1
author: Dotti Pease
